Oral GLP-1 Side Effects: Are They Different from Injectable?
GLP-1 medications cause similar side effects regardless of delivery format — the mechanism of action is the same. But there are some format-specific differences worth knowing about.
Common Side Effects (All Formats)
Nausea, vomiting, diarrhea, constipation, and decreased appetite are the most common GLP-1 side effects across both oral and injectable formulations. These are typically dose-dependent (worse at higher doses) and tend to improve over the first 4–8 weeks of treatment.
Oral-Specific Considerations
FDA-approved oral semaglutide (Wegovy): The SNAC absorption enhancer can cause additional upper GI effects, including heartburn and acid reflux, that are less common with injectable semaglutide. Taking the tablet as directed — empty stomach, small sip of water, 30-minute fast — minimizes these effects.
Foundayo (orforglipron): Clinical trials showed discontinuation rates of 8.7–9.7% with orforglipron versus 4.5–4.9% with oral semaglutide. The higher dropout rate suggests a somewhat rougher side-effect profile, though the specific nature of the side effects (primarily GI) was similar.
Sublingual drops: The most commonly reported format-specific issue is taste — bitter or metallic flavor that some patients find difficult to tolerate. This isn't a systemic side effect but can affect adherence. If taste is a dealbreaker, switch to capsules, tablets, or gummies.
Gummies: The sugar and sweetener content in gummy formulations can occasionally cause additional GI effects (bloating, gas) in sensitive patients. This is separate from the GLP-1 side effects themselves.
Injectable vs Oral: Injection-Site Reactions
One clear advantage of oral GLP-1s: no injection-site reactions. Redness, swelling, itching, and bruising at injection sites affect a meaningful percentage of injectable GLP-1 users. Switching to oral eliminates this entirely.